| abstract |
The invention relates to a specific cyclooxygenase 2ninhibitor which comprises, as an active ingredient, 2-(2,6-dichloro-4-hydroxyanilino)phenylaceticnacid represented bynthe following formula (1):n nor a salt thereof, and an anti-inflammatory agentncontaining the same. The compound specifically inhibitsncyclooxygenase 2 without inhibiting the cyclooxygenase 1nactivity. Thus, it scarcely causes any gastrointestinalndisorders as side effects. Further, it is low in toxicitynand safe. |